Skip to main content
. 2021 Jul 8;27:73. doi: 10.1186/s10020-021-00330-2

Fig. 1.

Fig. 1

Reduced circMTO1 expression in serum and ox-LDL-stimulated VSMCs. A, B The mRNA levels of circMTO1 and MTO1 in serum of AS patients (n = 55) and healthy volunteers (n = 55). C The mRNA levels of circMTO1 and MTO1 in VSMC treated with ox-LDL (0, 10, 20, 50 μg/ml) for 24 h. D The mRNA expression level of circMTO1 and MTO1 after treated with ox-LDL for different times (0, 12, 24 and 48 h).*P < 0.05, **P < 0.01 and ***P < 0.001